Explore › Outcome › No interest in food
Outcome

No interest in food

Also known as: Interest in reducing or stopping methamphetamine use (binary: interested vs not interested) Interest in reducing or stopping opioid use (binary: interested vs not interested) No interest in food No interest in food (finding) MA
9 findings 1 paper 5 related entities View in graph →

Related entities

interventions
Positive screening for depression on PHQ-9 (Patient Health Questionnaire 9)1 Targeted outreach to women who inject opioids1
conditions
Opioid Use Disorder2 History of methamphetamine use1
studys
PMC96326903

Findings (50)

None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →
None
improvement

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Size: AOR 2.19 CI: 95% CI: 1.11-4.29
PMC9632690
Finding details → · Paper → · Graph →

Papers (1)